Glyxambi 25/5Mg Tablet 30S

• Glyxambi 25/5mg combines empagliflozin 25mg and linagliptin 5mg for type 2 diabetes • Dual mechanism Tabletlet inhibiting SGLT-2 and DPP-4 for blood glucose control • Once daily oral Tabletlet for adults with type 2 diabetes as prescribed • Reduces blood glucose by increasing urinary glucose excretion and improving insulin response • Requires a valid prescription from a licensed physician or endocrinologist • Available at Medon Pharmacy UAE

Glyxambi 25/5mg Tabletlets combine empagliflozin 25mg and linagliptin 5mg in a single Tabletlet for type 2 diabetes management. The dual SGLT-2 and DPP-4 inhibitor mechanism provides complementary blood glucose lowering effects with a once-daily convenient Tabletlet. Benefits: • Supports comprehensive blood glucose control with a dual SGLT-2 and DPP-4 inhibitor • Helps lower blood glucose by increasing urinary glucose excretion via SGLT-2 inhibition • Promotes improved insulin response with linagliptin DPP-4 enzyme inhibition • Relieves the burden of managing two separate medications with a single combination Tabletlet • SuiTabletle for adults with type 2 diabetes as prescribed by a physician or endocrinologist How to Use: • Take one Tabletlet once daily in the morning with or without food as directed • Swallow whole with a glass of water without crushing or breaking the Tabletlet • Maintain adequate fluid intake throughout the day while taking this medication • Monitor blood glucose levels regularly as advised by your physician • Store in a cool dry place and keep out of reach of children